News
ImmunityBio, Inc. (NASDAQ: IBRX) has announced the execution of a $75 million equity financing with a single institutional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback